PortfoliosLab logoPortfoliosLab logo
WDNA vs. COMT
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

WDNA vs. COMT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WisdomTree BioRevolution Fund (WDNA) and iShares Commodities Select Strategy ETF (COMT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, WDNA achieves a 5.85% return, which is significantly lower than COMT's 39.67% return.


WDNA

1D
1.24%
1M
-0.73%
YTD
5.85%
6M
8.14%
1Y
45.86%
3Y*
2.45%
5Y*
-5.33%
10Y*

COMT

1D
0.78%
1M
-4.35%
YTD
39.67%
6M
39.06%
1Y
47.51%
3Y*
16.86%
5Y*
13.50%
10Y*
9.09%
*Multi-year figures are annualized to reflect compound growth (CAGR)

WDNA vs. COMT - Yearly Performance Comparison


2026 (YTD)20252024202320222021
WDNA
WisdomTree BioRevolution Fund
5.85%22.68%-14.18%-2.07%-26.29%-5.27%
COMT
iShares Commodities Select Strategy ETF
39.67%6.07%5.96%-6.56%19.45%8.71%

Correlation

The correlation between WDNA and COMT is -0.15, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.15

Correlation (3Y)
Calculated over the trailing 3-year period

-0.01

Correlation (5Y)
Calculated over the trailing 5-year period

0.07

Correlation (All Time)
Calculated using the full available price history since Jun 4, 2021

0.07

The correlation between WDNA and COMT shifts across timeframes, from -0.15 (1 year) to 0.07 (all time), reflecting how their relationship changes across market environments.

WDNA vs. COMT - Sectors Allocation Comparison


Sectors
WDNA
COMT

Healthcare

85.0%

-

Basic Materials

6.5%

-

Consumer Defensive

3.0%

-

Energy

1.1%

-

Communication Services

-

-

Consumer Cyclical

-

-

Financial Services

-

100.0%

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

WDNA
85.0%
COMT

-

Basic Materials

WDNA
6.5%
COMT

-

Consumer Defensive

WDNA
3.0%
COMT

-

Energy

WDNA
1.1%
COMT

-

Communication Services

WDNA

-

COMT

-

Consumer Cyclical

WDNA

-

COMT

-

Financial Services

WDNA

-

COMT
100.0%

Industrials

WDNA

-

COMT

-

Real Estate

WDNA

-

COMT

-

Technology

WDNA

-

COMT

-

Utilities

WDNA

-

COMT

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

WDNA vs. COMT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WDNA
WDNA Risk / Return Rank: 5757
Overall Rank
WDNA Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
WDNA Sortino Ratio Rank: 5555
Sortino Ratio Rank
WDNA Omega Ratio Rank: 4848
Omega Ratio Rank
WDNA Calmar Ratio Rank: 7878
Calmar Ratio Rank
WDNA Martin Ratio Rank: 5353
Martin Ratio Rank

COMT
COMT Risk / Return Rank: 7171
Overall Rank
COMT Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
COMT Sortino Ratio Rank: 6060
Sortino Ratio Rank
COMT Omega Ratio Rank: 6464
Omega Ratio Rank
COMT Calmar Ratio Rank: 9191
Calmar Ratio Rank
COMT Martin Ratio Rank: 7373
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WDNA vs. COMT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and iShares Commodities Select Strategy ETF (COMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


WDNACOMTDifference
Sharpe ratioReturn per unit of total volatility

-0.44

Sortino ratioReturn per unit of downside risk

-0.24

Omega ratioGain probability vs. loss probability

1.30

1.40

-0.10

Calmar ratioReturn relative to maximum drawdown

3.94

5.95

-2.01

Martin ratioReturn relative to average drawdown

8.95

14.11

-5.16

WDNA vs. COMT - Sharpe Ratio Comparison

The current WDNA Sharpe Ratio is 1.81, which is comparable to the COMT Sharpe Ratio of 2.24. The chart below compares the historical Sharpe Ratios of WDNA and COMT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


WDNACOMTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.81

2.24

-0.44

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.21

0.64

-0.86

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.48

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.21

0.20

-0.42

Drawdowns

WDNA vs. COMT - Drawdown Comparison

The maximum WDNA drawdown since its inception was -58.87%, which is greater than COMT's maximum drawdown of -51.89%. Use the drawdown chart below to compare losses from any high point for WDNA and COMT.


Loading charts...

Drawdown Indicators


WDNACOMTDifference

Max Drawdown

Largest peak-to-trough decline

-58.87%

-51.89%

-6.98%

Max Drawdown (1Y)

Largest decline over 1 year

-11.70%

-8.02%

-3.68%

Max Drawdown (3Y)

Largest decline over 3 years

-38.25%

-13.31%

-24.94%

Max Drawdown (5Y)

Largest decline over 5 years

-58.87%

-29.00%

-29.87%

Max Drawdown (10Y)

Largest decline over 10 years

-39.22%

Current Drawdown

Current decline from peak

-31.86%

-4.82%

-27.04%

Average Drawdown

Average peak-to-trough decline

-35.65%

-24.07%

-11.58%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.14%

3.38%

+1.76%

Volatility

WDNA vs. COMT - Volatility Comparison

The current volatility for WisdomTree BioRevolution Fund (WDNA) is 6.75%, while iShares Commodities Select Strategy ETF (COMT) has a volatility of 7.37%. This indicates that WDNA experiences smaller price fluctuations and is considered to be less risky than COMT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


WDNACOMTDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.75%

7.37%

-0.62%

Volatility (6M)

Calculated over the trailing 6-month period

16.39%

18.80%

-2.41%

Volatility (1Y)

Calculated over the trailing 1-year period

25.53%

21.29%

+4.24%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.04%

21.06%

+3.98%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.04%

18.89%

+6.15%

WDNA vs. COMT - Expense Ratio Comparison

WDNA has a 0.45% expense ratio, which is lower than COMT's 0.48% expense ratio.


Dividends

WDNA vs. COMT - Dividend Comparison

WDNA's dividend yield for the trailing twelve months is around 4.31%, less than COMT's 5.54% yield.


PositionTTM20252024202320222021202020192018201720162015
COMT
iShares Commodities Select Strategy ETF
5.54%7.74%4.90%5.19%29.79%17.79%0.36%2.61%11.65%5.16%0.52%1.44%
WDNA
WisdomTree BioRevolution Fund
4.31%4.57%0.75%0.80%0.38%0.10%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


WDNA and COMT have a correlation of -0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

COMT has higher volatility (7.37%) compared to WDNA (6.75%). In terms of maximum drawdown, WDNA dropped -58.87% vs COMT's -51.89%.

On 5-year performance, COMT leads with 13.50% vs -5.33% for WDNA. On fees, WDNA is cheaper at 0.45% per year. On volatility, WDNA has been the lower-risk option at 6.75%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, COMT has performed better with a 13.50% return vs -5.33%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

WDNA is cheaper with a 0.45% expense ratio, compared with 0.48% for COMT.

COMT has the higher dividend yield at 5.54%, compared with 4.31% for WDNA.

WDNA is categorized as Health & Biotech Equities, while COMT is Commodities. They also come from different issuers: WisdomTree and iShares. Their fees differ too: 0.45% for WDNA and 0.48% for COMT.

COMT currently has the higher Sharpe Ratio (2.24 vs 1.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for WDNA and COMT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer